Sakine Merve Aydın

Dr. Sakine Merve Aydın

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2025 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
NGNeset Gumusburun
Neset Gumusburun
SUSebati Sinan Urkmez
Sebati Sinan Urkmez
YUYesim Civil Urkmez
Yesim Civil Urkmez
SASakine Merve Aydın
Sakine Merve Aydın
BCBahtiyar Ciftci
Bahtiyar Ciftci

1 March 2023 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
PDF file
EAEmine Aytemiz
Emine Aytemiz
TÇTayfur Çift
Tayfur Çift
SASakine Merve Aydın
Sakine Merve Aydın
Background/Aim: Postpartum bleeding is a leading preventable cause of maternal death. Prolonged 3rd stage duration of labor and induction agents can increase postpartum bleeding. This study evaluated the effect of using a dinoprostone (PGE2) vaginal insert, a cervical ripening and labor induction agent, on the 3rd stage duration of labor and the amount of postpartum bleeding. Methods: This prospective cross-sectional study involved 301 patients with vaginal delivery between 01.10.2020 and 30.06.2021. Patients were separated into two groups: PGE2+oxytocin (Group A) and only oxytocin (Group B). They were compared in terms of prepartum and postpartum data, 3rd stage duration of labor, and the amount of blood loss in the first 18 h postpartum. Results: The median 3rd stage duration of labor was 8 min in Group A and 7 min in Group B (P=0.009). No significant differences were found between the groups in the amount of postpartum blood loss, percentage changes in hemoglobin and hematocrit values, or when patients were analyzed based on 3rd stage duration of labor (≤10 vs. >10 min). Severe postpartum hemorrhage (≥1000 ml) was associated with decreased gravida, increased body mass index, longer oxytocin use, and prolonged 3rd stage duration of labor in all patients. In Group A, severe postpartum hemorrhage was associated with decreased gravida, increased body mass index, and longer duration of PGE2 use. Conclusion: PGE2 prolonged the 3rd stage duration of labor, but this did not increase postpartum bleeding compared to oxytocin. However, an increase in the duration of PGE2 use was associated with postpartum hemorrhage. Therefore, shortening the duration may be considered in patients with additional risk for postpartum hemorrhage.

6 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SASakine Merve Aydın
Sakine Merve Aydın
NGNeset Gumusburun
Neset Gumusburun
NGNaziye Gurkan
Naziye Gurkan
Nazan YurtcuNazan Yurtcu
Nazan Yurtcu
Canan Soyer caliskanCanan Soyer caliskan
Canan Soyer caliskan
MYMuhammet Sahin Yılmaz
Muhammet Sahin Yılmaz
Background: The aim of this study was to evaluate the diagnostic performance of combined testicular function indices in patients with non-obstructive azoospermia and to investigate the clinical value of these indices in predicting the diagnosis of non-obstructive azoospermia and the success of testicular sperm extraction. Methods: This retrospective observational study included 224 male patients who underwent infertility assessment. The patients were classified into a normospermic group (n = 165) and a non-obstructive azoospermia group (n = 59). Serum anti-Müllerian hormone, follicle-stimulating hormone, luteinising hormone and total testosterone levels were assessed. The Testicular Function Index, the modified Testicular Function Index and the logarithmically transformed index were calculated. Patients in the non-obstructive azoospermia group underwent micro-TESE and were classified according to sperm retrieval status. Diagnostic performance was assessed using ROC analysis. Results: Among the 59 patients with non-obstructive azoospermia who underwent micro-TESE, sperm retrieval was successful in 26 patients and unsuccessful in 33 patients. In the non-obstructive azoospermia group, anti-Müllerian hormone and testosterone levels were lower, whilst follicle-stimulating hormone and luteinising hormone levels were higher (all p < 0.001). All combined indices were found to be significantly lower in the non-obstructive azoospermia group (all p < 0.001). In the ROC analysis, follicle-stimulating hormone demonstrated the highest discriminatory performance (AUC = 0.978). In the testicular sperm extraction analysis, anti-Müllerian hormone was found to be the marker with the highest performance (AUC = 0.930). Conclusions: (Follicle-stimulating hormone demonstrated the highest diagnostic performance for distinguishing non-obstructive azoospermia, whereas anti-Müllerian hormone was the strongest predictor of TESE success. Although the combined testicular function indices showed good diagnostic performance, they did not outperform these established hormonal markers and should therefore be regarded as complementary tools for the integrated assessment of testicular function. These findings should be considered exploratory and require further validation.

23 May 2026 in Anadolu Kliniği Tıp Bilimleri Dergisi
Verified
Journal Article
Open access
GEGonca Evci
Gonca Evci
DBDevran Bıldırcın
Devran Bıldırcın
SASakine Merve Aydın
Sakine Merve Aydın
Aim: This study aimed to evaluate fertility outcomes in patients managed with medical treatment, surgical treatment, or expectant management for ectopic pregnancy.Methods: Patients aged 18–45 years who were diagnosed with ectopic pregnancy at the Obstetrics and Gynecology outpatient clinics of Ondokuz Mayıs University between January 2015 and December 2020 were retrospectively evaluated. Patients were categorized into three groups based on treatment modality: medical, surgical, or expectant management. Demographic characteristics, risk factors for ectopic pregnancy, baseline β-hCG levels, treatment success, recurrence rates, and subsequent spontaneous intrauterine pregnancy outcomes were collected and statistically analyzed.Results: A total of 314 patients were included in the study. There was no statistically significant difference among treatment groups regarding age, previous pregnancy history, or ectopic pregnancy risk factors (all p > 0.05). Treatment success rates differed significantly among groups, with the highest in the surgical group (98.6%), followed by the expectant management (94.1%) and medical treatment (72.5%) groups (p < 0.001). Recurrent ectopic pregnancy rates were comparable among groups without a statistically significant difference (p=0.28). Spontaneous intrauterine pregnancy rates during follow-up differed significantly among treatment groups (40.0% in the medical group, 27.6% in the surgical group, and 52.9% in the expectant group; p = 0.02). Baseline β-hCG levels were not significantly associated with treatment success in any treatment modality.Conclusion: Spontaneous intrauterine pregnancy outcomes differed among treatment modalities in patients with ectopic pregnancy, with lower rates observed following surgical management. These findings suggest an association between treatment modality and subsequent fertility outcomes; however, prospective controlled studies are required to establish causal relationships.

16 January 2026 in Genel Tıp Dergisi
Verified
Journal Article
Closed access
YÜYeşim Civil Ürkmez
Yeşim Civil Ürkmez
SASakine Merve Aydın
Sakine Merve Aydın
SÜSebati Sinan Ürkmez
Sebati Sinan Ürkmez
Canan Soyer caliskanCanan Soyer caliskan
Canan Soyer caliskan
NGNeset Gumusburun
Neset Gumusburun
Aim: Gestational diabetes mellitus is a common metabolic disorder that threatens both maternal and fetal health during pregnancy. In this study, serum GAS6 levels were evaluated in pregnant women with gestational diabetes mellitus and their relationship with oral glucose tolerance test results and neonatal findings were analysed.Materials and Methods: The study included 91 pregnant women with gestational diabetes and 86 healthy pregnant women who underwent 75 g oral glucose tolerance test between 24-28 weeks of gestation. Serum GAS6 levels were measured by ELISA in additional blood samples obtained during the oral glucose tolerance test. GAS6 levels were compared with maternal and neonatal parameters and their diagnostic value was evaluated by ROC analysis.Results: GAS6 levels were significantly higher in the gestational diabetes group. High GAS6 levels were associated with caesarean section rate, neonatal intubation and need for intensive care. ROC analysis showed that GAS6 had a high diagnostic performance (AUC: 0.91).Conclusions: Serum GAS6 levels can be considered as a potential biomarker in the diagnosis of gestational diabetes. It may also contribute to clinical applications in terms of predicting perinatal outcomes.

24 September 2026 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
SSSercan Serin
Sercan Serin
EKEmine Ahu Koç
Emine Ahu Koç
SASakine Merve Aydın
Sakine Merve Aydın
GÜGökhan Ünver
Gökhan Ünver
BABahattin Avcı
Bahattin Avcı